Overview

Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using exemestane may fight breast cancer by reducing the production of estrogen. It is not yet known if exemestane is more effective than tamoxifen in preventing the recurrence of breast cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of exemestane with that of tamoxifen in treating postmenopausal women who have undergone surgery to remove early-stage breast cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Cancer Research Campaign Clinical Trials Centre
Treatments:
Exemestane
Tamoxifen